A Comprehensive Guide to Clinical Investigations: Content and Modifications in the EU – MDCG Guidance Introduction: Clinical investigations play a...
A Comprehensive Guide to MDCG’s Clinical Investigations: Part 2 in the EU In the European Union (EU), the Medical Device...
Orexa Commences Phase 2 Trial in Post-Operative Patients with First Patient Dosed – Drugs.com MedNews Orexa Pharmaceuticals, a leading biopharmaceutical...
An Informative Overview of 15 Different Aspects of Change in Clinical Trial Start-Up and Execution Clinical trials play a crucial...
Phase I Thromboembolic Disorder Trial Commences Subject Dosing by Sirius Sirius Pharmaceuticals, a leading biopharmaceutical company, has announced the commencement...
Understanding the Implications of Gilead’s Trodelvy Challenges and Elevation Oncology’s Unexpected Success In the world of oncology, the development and...
Analysis of Phase 1 TQT/QT Study Interval in BioPharma Services Phase 1 TQT/QT studies are an essential component of drug...
Understanding the Role of a Phase 1 Clinical Study Protocol Champion at BioPharma Services In the world of clinical research,...
The Food and Drug Administration (FDA) has recently granted Fast Track designation to Kyverna Therapeutics’ experimental drug, KYV-101, for the...
Title: Promising Results: First Patient in Phase 1 Clinical Trial of PMB-CT01 Achieves Complete Remission for Relapsed and Refractory B-cell...
The U.S. Food and Drug Administration (FDA) has recently expanded its approval of Vertex Pharmaceuticals’ CRISPR-based medicine for the treatment...
Alnylam Pharmaceuticals, a leading biopharmaceutical company focused on RNA interference (RNAi) therapeutics, recently released its preliminary financial results for the...
Alfasigma SpA, an Italian pharmaceutical company, and Galapagos NV, a Belgian biotechnology company, have recently announced a significant collaboration agreement...
DA-1726 IND Application Submitted to FDA for Phase 1 Clinical Trial in Obesity Treatment Obesity has become a global epidemic,...
Zevra Therapeutics, a biopharmaceutical company focused on developing innovative treatments for rare and neurodegenerative diseases, has recently resubmitted its New...
